Ausgabe 13/2023
Inhalt (37 Artikel)
Luca Giovanella. Integrated Diagnostics and Theranostics of Thyroid Diseases
Luigi Mansi
[18F]Fluoropivalate, mitochondria, and the resurrection of short-chain fatty acids
Luca Filippi, Laura Evangelista, Orazio Schillaci
Exploring coronary microvascular function by quantitative CZT-SPECT: a small step or giant leap for INOCA patients?
Adriana D’Antonio, Teresa Mannarino
Inside Brazilian nuclear medicine: numbers, projections and behaviors
Marlon da Silva Brandão Rodrigues, Tais Monteiro Magne, Ralph Santos-Oliveira
Boosting the acceptance of 18F-FET PET for image-guided treatment planning with a multi-centric prospective trial
Karl-Josef Langen, Norbert Galldiks, Philipp Lohmann, Felix M. Mottaghy
Aging imaging: the future demand of health management
Yan Zhong, Chentao Jin, Xiaohui Zhang, Rui Zhou, Xiaofeng Dou, Jing Wang, Mei Tian, Hong Zhang
Letter to the Editor: The theoretical challenges of routinely using [18F]FDG PET/MRI combined with chest HRCT for early cancer detection in asymptomatic patients
Paulo Schiavom Duarte
Error mitigation enables PET radiomic cancer characterization on quantum computers
S. Moradi, Clemens Spielvogel, Denis Krajnc, C. Brandner, S. Hillmich, R. Wille, T. Traub-Weidinger, X. Li, M. Hacker, W. Drexler, L. Papp
Preclinical evaluation and pilot clinical study of [68Ga]Ga-THP-APN09, a novel PD-L1 targeted nanobody radiotracer for rapid one-step radiolabeling and PET imaging
Xiaopan Ma, Xin Zhou, Biao Hu, Xiaoda Li, Meinan Yao, Liqiang Li, Xue Qin, DaPeng Li, Yuan Yao, Xingguo Hou, Song Liu, Yan Chen, Zilei Wang, Wenyuan Zhou, Nan Li, Hua Zhu, Bing Jia, Zhi Yang
Side-by-side comparison of the two widely studied GRPR radiotracers, radiolabeled NeoB and RM2, in a preclinical setting
T. S. T. Damiana, P. Paraïso, C. de Ridder, D. Stuurman, Y. Seimbille, S. U. Dalm
EANM procedural recommendations for managing the paediatric patient in diagnostic nuclear medicine
Luca Camoni, Andrea Santos, Marie Luporsi, Ana Grilo, Agata Pietrzak, Jonathan Gear, Pietro Zucchetta, Zvi Bar-Sever
Variability of [18F]FDG-PET/LDCT reporting in vascular graft and endograft infection
David J. Liesker, Stijn Legtenberg, Paola A. Erba, Andor W. J. M. Glaudemans, Clark J. Zeebregts, Jean-Paul P. M. De Vries, Nabil Chakfé, Ben R. Saleem, Riemer H. J. A. Slart
New thresholds in semi-quantitative [18F]FDG PET/CT are needed to assess large vessel vasculitis with long-axial field-of-view scanners
Luisa Knappe, Carola Bregenzer, Nasir Gözlügöl, Clemens Mingels, Ian Alberts, Axel Rominger, Federico Caobelli
Impact of cardiac history and myocardial scar on increase of myocardial perfusion after revascularization
Ruurt A. Jukema, Ruben W. de Winter, Luuk H.G.A. Hopman, Roel S. Driessen, Pepijn A. van Diemen, Yolande Appelman, Jos W.R. Twisk, R. Nils Planken, Pieter G. Raijmakers, Paul Knaapen, Ibrahim Danad
Prevalence of ATTR-CA and high-risk features to guide testing in patients referred for TAVR
Bryan Abadie, Adel Hajj Ali, Trejeeve Martyn, Andrew Higgins, Amar Krishnaswamy, Grant Reed, Rishi Puri, James Yun, Paul Cremer, Mazen Hanna, W. H. Wilson Tang, Samir Kapadia, Wael Jaber
Quantification of P-glycoprotein function at the human blood-brain barrier using [18F]MC225 and PET
Pascalle Mossel, Wejdan M. Arif, Giordana Salvi De Souza, Lara Garcia Varela, Chris W. J. van der Weijden, Hendrikus H. Boersma, Antoon T. M. Willemsen, Ronald Boellaard, Philip H. Elsinga, Ronald J. H. Borra, Rudi A. J. O. Dierckx, Adriaan A. Lammertsma, Anna L. Bartels, Gert Luurtsema
Association of protein distribution and gene expression revealed by positron emission tomography and postmortem gene expression in the dopaminergic system of the human brain
Yasuharu Yamamoto, Keisuke Takahata, Manabu Kubota, Hiroyoshi Takeuchi, Sho Moriguchi, Takeshi Sasaki, Chie Seki, Hironobu Endo, Kiwamu Matsuoka, Kenji Tagai, Yasuyuki Kimura, Shin Kurose, Masaru Mimura, Kazunori Kawamura, Ming-Rong Zhang, Makoto Higuchi
[99mTc]Tc-PentixaTec: development, extensive pre-clinical evaluation, and first human experience
Matthias Konrad, Andreas Rinscheid, Georgine Wienand, Bernd Nittbaur, Hans-Jürgen Wester, Tilman Janzen, Constantin Lapa, Christian Helmut Pfob, Margret Schottelius
Robust deep learning-based PET prognostic imaging biomarker for DLBCL patients: a multicenter study
Chong Jiang, Chunjun Qian, Zekun Jiang, Yue Teng, Ruihe Lai, Yiwen Sun, Xinye Ni, Chongyang Ding, Yuchao Xu, Rong Tian
Feasibility of acquisitions using total-body PET/CT with a half-dose [68Ga]Ga-FAPI-04 activity in oncology patients
Zijun Chen, Yining Wang, Xinlan Yang, Lianghua Li, Yanmiao Huo, Xiaofeng Yu, Xiuying Xiao, Chenpeng Zhang, Yumei Chen, Haitao Zhao, Yun Zhou, Gang Huang, Jianjun Liu, Ruohua Chen
Delineation and agreement of FET PET biological volumes in glioblastoma: results of the nuclear medicine credentialing program from the prospective, multi-centre trial evaluating FET PET In Glioblastoma (FIG) study—TROG 18.06
Nathaniel Barry, Roslyn J. Francis, Martin A. Ebert, Eng-Siew Koh, Pejman Rowshanfarzad, Ghulam Mubashar Hassan, Jake Kendrick, Hui K. Gan, Sze T. Lee, Eddie Lau, Bradford A. Moffat, Greg Fitt, Alisha Moore, Paul Thomas, David A. Pattison, Tim Akhurst, Ramin Alipour, Elizabeth L. Thomas, Edward Hsiao, Geoffrey P. Schembri, Peter Lin, Tam Ly, June Yap, Ian Kirkwood, Wilson Vallat, Shahroz Khan, Dayanethee Krishna, Stanley Ngai, Chris Yu, Scott Beuzeville, Tow C. Yeow, Dale Bailey, Olivia Cook, Angela Whitehead, Rachael Dykyj, Alana Rossi, Andrew Grose, Andrew M. Scott
Feasibility of [18F]fluoropivalate hybrid PET/MRI for imaging lower and higher grade glioma: a prospective first-in-patient pilot study
Shahriar Islam, Marianna Inglese, Matthew Grech-Sollars, Preetha Aravind, Suraiya Dubash, Tara D. Barwick, Kevin O’Neill, James Wang, Azeem Saleem, James O’Callaghan, Giulio Anchini, Matthew Williams, Adam Waldman, Eric O. Aboagye
Multi-task deep learning-based radiomic nomogram for prognostic prediction in locoregionally advanced nasopharyngeal carcinoma
Bingxin Gu, Mingyuan Meng, Mingzhen Xu, David Dagan Feng, Lei Bi, Jinman Kim, Shaoli Song
A common [18F]-FDG PET radiomic signature to predict survival in patients with HPV-induced cancers
Stephane Niyoteka, Romain-David Seban, Rahimeh Rouhi, Andrew Scarsbrook, Catherine Genestie, Marion Classe, Alexandre Carré, Roger Sun, Agustina La Greca Saint-Esteven, Cyrus Chargari, Jack McKenna, Garry McDermott, Eirik Malinen, Stephanie Tanadini-Lang, Matthias Guckenberger, Marianne G. Guren, Claire Lemanski, Eric Deutsch, Charlotte Robert
[18F]FDG PET/CT for predicting triple-negative breast cancer outcomes after neoadjuvant chemotherapy with or without pembrolizumab
Romain-David Seban, Emilie Arnaud, Delphine Loirat, Luc Cabel, Paul Cottu, Lounes Djerroudi, Segolene Hescot, Pierre Loap, Claire Bonneau, Francois-Clement Bidard, Virginie Huchet, Nina Jehanno, Arnaud Berenbaum, Laurence Champion, Irene Buvat
Comparing the clinical value of baseline [68 Ga]Ga-FAPI-04 PET/CT and [18F]F-FDG PET/CT in pancreatic ductal adenocarcinoma: additional prognostic value of the distal pancreatitis
Jie Ding, Jiangdong Qiu, Zhixin Hao, Hua Huang, Qiaofei Liu, Wenjing Liu, Chao Ren, Marcus Hacker, Taiping Zhang, Wenming Wu, Xiang Li, Li Huo
[18F] AlF‑NOTA‑FAPI‑04 PET/CT as a promising tool for imaging fibroblast activation protein in gastrointestinal system cancers: a prospective investigation of comparative analysis with 18F-FDG
Liping Yang, Shichuan Xu, Liang Cheng, Chao Gao, Shaodong Cao, Zhengsong Chang, Kezheng Wang
[68Ga]Ga-FAPI-04 PET/CT in the evaluation of epithelial ovarian cancer: comparison with [18F]F-FDG PET/CT
Jie Chen, Kui Xu, Chongjiao Li, Yueli Tian, Ling Li, Bing Wen, Can He, Hongbing Cai, Yong He
Prognostic utility of RECIP 1.0 with manual and AI-based segmentations in biochemically recurrent prostate cancer from [68Ga]Ga-PSMA-11 PET images
Jake Kendrick, Roslyn J Francis, Ghulam Mubashar Hassan, Pejman Rowshanfarzad, Jeremy SL Ong, Michael McCarthy, Sweeka Alexander, Martin A Ebert
Modified PROMISE criteria for standardized interpretation of gastrin-releasing peptide receptor (GRPR)-targeted PET
Heying Duan, Guido A. Davidzon, Farshad Moradi, Tie Liang, Hong Song, Andrei Iagaru
Total-body [68 Ga]Ga-PSMA-11 PET/CT improves detection rate compared with conventional [68 Ga]Ga-PSMA-11 PET/CT in patients with biochemical recurrent prostate cancer
Yining Wang, Zijun Chen, Yinjie Zhu, Haitao Zhao, Lianghua Li, Gang Huang, Wei Xue, Ruohua Chen, Jianjun Liu
One stop non-invasive identification of culprit vessels and related ischemia in coronary artery bypass patient using combined 82Rubidium PET/coronary CT angiography
Ujwal Bhure, Matthias Bossard, Hannes Grünig, Maria del Sol Pérez Lago, Florim Cuculi, Klaus Strobel
Comparison of 99mTc radiolabeled somatostatin antagonist with [68 Ga]Ga-DOTA-TATE in a patient with advanced neuroendocrine tumor
Marta Opalinska, Luka Lezaic, Clemens Decristoforo, Petra Kolenc, Renata Mikolajczak, Andrej Studen, Urban Simoncic, Irene Virgolini, Malgorzata Trofimiuk-Muldner, Piotr Garnuszek, Christine Rangger, Melpomeni Fani, Boguslaw Glowa, Konrad Skorkiewicz, Alicja Hubalewska-Dydejczyk
[68Ga]Ga-DOTA-FAPI-04 PET/CT depicts metastases from medullary thyroid cancer that [68Ga]Ga-DOTATOC PET/CT missed
Akram Al-Ibraheem, Salem Fandi Alyasjeen, Ahmed Saad Abdlkadir, Areej Abu Sheikha
Correction to: Highlights of the 35th EANM Annual Congress 2022, onsite edition in Barcelona, Spain: “FROM BARCELONA WITH LOVE”
Nathalie L. Albert, Philippe Garrigue, Benjamin Guillet, Irene A. Burger
Correction to: Next‑generation PET/CT imaging in meningioma—first clinical experiences using the novel SSTR‑targeting peptide [18F]SiTATE
Marcus Unterrainer, Sophie C. Kunte, Lena M. Unterrainer, Adrien Holzgreve, Astrid Delker, Simon Lindner, Leonie Beyer, Matthias Brendel, Wolfgang G. Kunz, Michael Winkelmann, Clemens C. Cyran, Jens Ricke, Klaus Jurkschat, Carmen Wängler, Björn Wängler, Ralf Schirrmacher, Claus Belka, Maximilian Niyazi, Joerg‑Christian Tonn, Peter Bartenstein, Nathalie L. Albert